IHM
LAB icon

Iguana Healthcare Management’s Standard BioTools LAB Stock Holding History

Iguana Healthcare Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-50,000
Closed -$452K – 90
2016
Q2 		$452K Sell
50,000
-50,000
-50% -$470K 0.18% 77
2016
Q1 		$807K Buy
+100,000
New +$721K 0.3% 64

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EA
Emerald Acquisition Seattle, Washington $51.8B AUM
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Iguana Healthcare Management's LAB Position: Q3 2016 in Review

Iguana Healthcare Management sold out of Standard BioTools (LAB) in Q3 2016, closing a stake of 50,000 shares — an estimated $452K sold.

Iguana Healthcare Management first reported a position in LAB in Q1 2016 and held it in 2 quarters. The position peaked at $807K in Q1 2016. 98 funds tracked by Wall St. Rank hold LAB as of Q3 2016.

  • Iguana Healthcare Management reported no remaining Standard BioTools position as of Q3 2016 after selling out during the quarter.
  • Iguana Healthcare Management sold 50,000 Standard BioTools shares in Q3 2016, an estimated $452K.
  • Iguana Healthcare Management first reported a position in Standard BioTools in Q1 2016 and held it in 2 quarters.
  • Iguana Healthcare Management's Standard BioTools position peaked at $807K in Q1 2016.
  • 98 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2016.

Based on Iguana Healthcare Management's 13F filing for Q3 2016, filed 14 Nov 2016.